Skip to content
healthcare.dev

Triple Antibiotic

NDC 54473-291, Bacitracin zinc and Neomycin and Polymyxin B sulfate, ointment, from Melaleuca, Inc..

Product NDC
54473-291
Status
Listed
Labeler
Melaleuca, Inc.
Dosage form
OINTMENT
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M004
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/54473-291 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BACITRACIN ZINC500 U/g
  • NEOMYCIN SULFATE3.5 mg/g
  • POLYMYXIN B SULFATE10000 U/g

Pharmacologic classes

Aminoglycoside Antibacterial [EPC]; Aminoglycosides [CS]; Decreased Cell Wall Synthesis & Repair [PE]; Polymyxin-class Antibacterial [EPC]; Polymyxins [CS]

Package NDCNDC-11Package
54473-291-015447302910114 g in 1 TUBE (54473-291-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 54473-291 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/54473-291 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 54473-291. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.